|
1
|
Valle JW, Lamarca A, Goyal L, Barriuso J
and Zhu AX: New horizons for precision medicine in biliary tract
cancers. Cancer Discov. 7:943–962. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer Statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu ZY, Cao J, Zhang JT, Xu GL, Li XP,
Wang FT, Ansari KH, Mohamed H and Fan YZ: Ring finger protein 125,
as a potential highly aggressive and unfavorable prognostic
biomarker, promotes the invasion and metastasis of human
gallbladder cancers via activating the TGF-β1-SMAD3-ID1 signaling
pathway. Oncotarget. 8:49897–49914. 2017.PubMed/NCBI
|
|
5
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
6
|
Horgan AM, Amir E, Walter T and Knox JJ:
Adjuvant therapy in the treatment of biliary tract cancer: A
systematic review and meta-analysis. J Clin Oncol. 30:1934–1940.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malka D, Cervera P, Foulon S, Trarbach T,
de la Fouchardière C, Boucher E, Fartoux L, Faivre S, Blanc JF,
Viret F, et al: Gemcitabine and oxaliplatin with or without
cetuximab in advanced biliary-tract cancer (BINGO): A randomised,
open-label, non-comparative phase 2 trial. Lancet Oncol.
15:819–828. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liotta L and Kohn E: The microenvironment
of the tumour-host interface. Nature. 411:375–379. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JB, Stein R and O'Hare MJ:
Tumour-stromal interactions in breast cancer: The role of stroma in
tumourigenesis. Tumour Biol. 26:173–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reisfeld R: The tumor microenvironment: A
target for combination therapy of breast cancer. Crit Rev Oncog.
18:115–133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Finak G, Bertos N, Pepin F, Sadekova S,
Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu
A, et al: Stromal gene expression predicts clinical outcome in
breast cancer. Nat Med. 14:518–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ahn S, Cho J, Sung J, Lee JE, Nam SJ, Kim
KM and Cho EY: The prognostic significance of tumor-associated
stroma in invasive breast carcinoma. Tumor Biol. 33:1573–1580.
2012. View Article : Google Scholar
|
|
13
|
Shi S, Liang C, Xu J, Meng Q, Hua J, Yang
X, Ni Q and Yu X: The strain ratio as obtained by endoscopic
ultrasonography elastograhy correlates with the stroma proportion
and the prognosis of local pancreatic cancer. Ann Surg. 2018.
View Article : Google Scholar
|
|
14
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao Q, Wang XY, Qiu SJ, Zhou J, Shi YH,
Zhang BH and Fan J: Tumor stroma reaction-related gene signature
predicts clinical outcome in human hepatocellular carcinoma. Cancer
Sci. 102:1522–1531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Herrera M, Herrera A, Domínguez G, Silva
J, García V, García JM, Gómez I, Soldevilla B, Muñoz C, Provencio
M, et al: Cancer-associated fibroblast and M2 macrophage markers
together predict outcome in colorectal cancer patients. Cancer Sci.
104:437–444. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Micke P and Ostman A: Tumour-stroma
interaction: Cancer-associated fibroblasts as novel targets in
anti-cancer therapy? Lung Cancer. 45 (Suppl 2):S163–S175. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johansson AC, Ansell A, Jerhammar F, Lindh
MB, Grénman R, Munck-Wikland E, Östman A and Roberg K:
Cancer-associated fibroblasts induce matrix
metalloproteinase-mediated cetuximab resistance in head and neck
squamous cell carcinoma cells. Mol Cancer Res. 10:1158–1168. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Affolter A, Schmidtmann I, Mann WJ and
Brieger J: Cancer-associated fibroblasts do not respond to combined
irradiation and kinase inhibitor treatment. Oncol Rep. 29:785–790.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gonda TA, Varro A, Wang TC and Tycko B:
Molecular biology of cancer-associated fibroblasts: Can these cells
be targeted in anti-cancer therapy? Semin Cell Dev Biol. 21:2–10.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Al-Ansari MM, Hendrayani SF, Tulbah A,
Al-Tweigeri T, Shehata AI and Aboussekhra A: p16INK4A represses
breast stromal fibroblasts migration/invasion and their
VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
Neoplasia. 14:1269–1277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mertens JC, Fingas CD, Christensen JD,
Smoot RL, Bronk SF, Werneburg NW, Gustafson MP, Dietz AB, Roberts
LR, Sirica AE, et al: Therapeutic effects of deleting
cancer-associated fibroblasts in cholangiocarcinoma. Cancer Res.
73:897–907. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Olive KP, Jacobetz MA, Davidson CJ,
Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA,
Caldwell ME, Allard D, et al: Inhibition of Hedgehog signaling
enhances delivery of chemotherapy in a mouse model of pancreatic
cancer. Science. 324:1457–1461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Altenhöfer S, Kleikers PW, Radermacher KA,
Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K and
Schmidt HH: The NOX toolbox: Validating the role of NADPH oxidases
in physiology and disease. Cell Mol Life Sci. 69:2327–2343. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bartosz G: Reactive oxygen species:
Destroyers or messengers? Biochem Pharmacol. 77:1303–1315. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schröder K: Isoform specific functions of
Nox protein-derived reactive oxygen species in the vasculature.
Curr Opin Pharmacol. 10:122–126. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kamata T: Roles of Nox1 and other Nox
isoforms in cancer development. Cancer Sci. 100:1382–1388. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H,
Jiang G, Lu J, Antony S and Doroshow JH: NADPH oxidases and cancer.
Clin Sci (Lond). 128:863–875. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
You X, Ma M, Hou G, Hu Y and Shi X: Gene
expression and prognosis of NOX family members in gastric cancer.
Onco Targets Ther. 11:3065–3074. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Augusto AC, Miguel F, Mendonça S,
Pedrazzoli J Jr and Gurgueira SA: Oxidative stress expression
status associated to Helicobacter pylori virulence in
gastric diseases. Clin Biochem. 40:615–622. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Montalvo-Javé EE, Olguín-Martínez M,
Hernández-Espinosa DR, Sánchez-Sevilla L, Mendieta-Condado E,
Contreras-Zentella ML, Oñate-Ocaña LF, Escalante-Tatersfield T,
Echegaray-Donde A, Ruiz-Molina JM, et al: Role of NADPH oxidases in
inducing a selective increase of oxidant stress and cyclin D1 and
checkpoint 1 over-expression during progression to human gastric
adenocarcinoma. Eur. J Cancer. 57:50–57. 2016.
|
|
32
|
Eun HS, Cho SY, Joo JS, Kang SH, Moon HS,
Lee ES, Kim SH and Lee BS: Gene expression of NOX family members
and their clinical significance in hepatocellular carcinoma. Sci
Rep. 7:110602017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Linder N, Konsti J, Turkki R, Rahtu E,
Lundin M, Nordling S, Haglund C, Ahonen T, Pietikäinen M and Lundin
J: Identification of tumor epithelium and stroma in tissue
microarrays using texture analysis. Diagn Pathol. 7:222012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lehr HA, van der Loos CM, Teeling P and
Gown AM: Complete chromogen separation and analysis in double
immunohistochemical stains using Photoshop-based image analysis. J
Histochem Cytochem. 47:119–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zou A, Lambert D, Yeh H, Yasukawa K,
Behbod F, Fan F and Cheng N: Elevated CXCL1 expression in breast
cancer stroma predicts poor prognosis and is inversely associated
with expression of TGF-β signaling proteins. BMC Cancer.
14:7812014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suh YA, Arnold RS, Lassegue B, Shi J, Xu
X, Sorescu D, Chung AB, Griendling KK and Lambeth JD: Cell
transformation by the superoxide-generating oxidase Mox1. Nature.
401:79–82. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Arbiser JL, Petros J, Klafter R,
Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy
S, Arnold RS and Lambeth JD: Reactive oxygen generated by Nox1
triggers the angiogenic switch. Proc Natl Acad Sci USA. 99:715–720.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Illeperuma RP, Kim DK, Park YJ, Son HK,
Kim JY and Kim J, Lee DY, Kim KY, Jung DW, Tilakaratne WM and Kim
J: Areca nut exposure increases secretion of tumor-promoting
cytokines in gingival fibroblasts that trigger DNA damage in oral
keratinocytes. Int J Cancer. 137:2545–2557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Franco OE, Shaw AK, Strand DW and Hayward
SW: Cancer associated fibroblasts in cancer pathogenesis. Semin
Cell Dev Biol. 21:33–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pecqueux C, Arslan A, Heller M,
Falkenstein M, Kaczorowski A, Tolstov Y, Sültmann H, Grüllich C,
Herpel E, Duensing A, et al: FGF-2 is a driving force for
chromosomal instability and a stromal factor associated with
adverse clinico-pathological features in prostate cancer. Urol
Oncol. 36:365.e15–365.e26. 2018. View Article : Google Scholar
|
|
42
|
Zhang D, Li L, Jiang H, Li Q, Wang-Gillam
A, Yu J, Head R, Liu J, Ruzinova MB and Lim KH: Tumor-stroma
IL1β-IRAK4 feedforward circuitry drives tumor fibrosis,
chemoresistance, and poor prognosis in pancreatic cancer. Cancer
Res. 78:1700–1712. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wikberg ML, Edin S, Lundberg IV, Van
Guelpen B, Dahlin AM, Rutegård J, Stenling R, Oberg A and Palmqvist
R: High intratumoral expression of fibroblast activation protein
(FAP) in colon cancer is associated with poorer patient prognosis.
Tumour Biol. 34:1013–1020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schoppmann SF, Berghoff A, Dinhof C,
Jakesz R, Gnant M, Dubsky P, Jesch B, Heinzl H and Birner P:
Podoplanin-expressing cancer-associated fibroblasts are associated
with poor prognosis in invasive breast cancer. Breast Cancer Res
Treat. 134:237–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhan M, Wang H, Chen T, Chen W, Yang L, He
M, Xu S and Wang J: NOX1 mediates chemoresistance via HIF1α/MDR1
pathway in gallbladder cancer. Biochem Biophys Res Commun.
468:79–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
